Risk Stratification of Short Term Sudden Death after Acute Coronary Syndrome
Abstract
Sudden cardiac death is the leading cause of cardiovascular mortality in acute coronary syndrome. Risk stratification scoring tools are available to better identify patients at risk after acute myocardial infarction. In addition plenty of factors and treatment modalities modulate the risk of sudden cardiac death.A case of in-hospital SCD in a young woman with acute anterior STEMI is presented as a trigger to the importance of risk stratification and treatment according to guidelines in preventing SCD.
Downloads
Download data is not yet available.
References
Vital Statistics of the U.S., Data Warehouse, National Center for Health Statistics.
Nichol G. Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome JAMA. 2008;300:1423-1431.
Antman EM. ST elevation myocardial infarction : Management. In: Braunwald E, ed. BRAUNWALD’S HEART DISEASE: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia: Saunders Elsevier; 2008.
Myerburg RJ. Cardiac Arrest and Sudden Cardiac Death. In: Braunwald E, ed. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Vol 1. 8th ed ed. Philadelphia: Saunders Elsevier; 2008.
Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA, Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003; 163(19):2345-53.
Armstrong PW, Fu Y, Chang WC, et al. Acute coronary syndromes in the GUSTO-IIb Trial, prognostic insights and impact of recurrent ischemia. Circulation. 1998;98:1860–8.
Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ. 2006;333:1091.
Killip T, Kimball JT. Treatment of myocardial infarction in coronary care unit. A two-year experience with 250 patients. Am J Cardiol. 1967;20:457–467.
David A. Morrow M, M. E, Antman M, Andrew Charlesworth B, Richard Cairns B, Sabina A. Murphy M, et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 2000;102:2031.
Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001 May 5;357:1385-90.
DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O’Keefe JH. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013;111(5):765-9.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765-775.
Nichol G. Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome JAMA. 2008;300:1423-1431.
Antman EM. ST elevation myocardial infarction : Management. In: Braunwald E, ed. BRAUNWALD’S HEART DISEASE: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia: Saunders Elsevier; 2008.
Myerburg RJ. Cardiac Arrest and Sudden Cardiac Death. In: Braunwald E, ed. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Vol 1. 8th ed ed. Philadelphia: Saunders Elsevier; 2008.
Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA, Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003; 163(19):2345-53.
Armstrong PW, Fu Y, Chang WC, et al. Acute coronary syndromes in the GUSTO-IIb Trial, prognostic insights and impact of recurrent ischemia. Circulation. 1998;98:1860–8.
Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ. 2006;333:1091.
Killip T, Kimball JT. Treatment of myocardial infarction in coronary care unit. A two-year experience with 250 patients. Am J Cardiol. 1967;20:457–467.
David A. Morrow M, M. E, Antman M, Andrew Charlesworth B, Richard Cairns B, Sabina A. Murphy M, et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 2000;102:2031.
Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001 May 5;357:1385-90.
DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O’Keefe JH. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013;111(5):765-9.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765-775.
Published
2014-03-04
Views & Downloads
Abstract views: 2931
PDF downloads: 1789
PDF downloads: 1789
How to Cite
Endang, J., Suprobo, D., Prakoso, R., Yuniadi, Y., Siswanto, B., & Hersunarti, N. (2014). Risk Stratification of Short Term Sudden Death after Acute Coronary Syndrome. Indonesian Journal of Cardiology, 34(2), 98-104. https://doi.org/10.30701/ijc.v34i2.327
Section
Case Reports
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).